A VR View: Severe Uncontrolled Asthma: Phenotypes, Endotypes, and Treatment Response Decisions
Friday, November 8, 2019
8:00PM – 8:15PM: Registration/Reception
8:15PM – 10:00PM: Symposium
1600 Lamar St,
Houston, TX 77010
Meeting Room: D and E
- VIRTUAL REALITY SETS provided to all attendees for viewing this presentation only
- Interactive, case-based learning environment
- Create your own personalized poster
- iPads provided to enhance learning experience and enable real-time Q&A
Michael E. Wechsler, MD, MMSc
Director, Asthma Program
Department of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health
After completing the CME activity, learners should be better able to:
- Review how the varying inflammatory profiles of the different asthma phenotypes can inform the development of new treatments for severe uncontrolled asthma
- Evaluate the usefulness of phenotypic- or endotypic-specific biomarkers in diagnosing, classifying, and controlling severe uncontrolled asthma
- Develop treatment plans individualized for each patient with severe asthma accounting for specific patient factors, current evidence-based guidance, and the clinical profiles of current treatments
This initiative is designed to meet the educational needs of pulmonologists, allergists, immunologists, ENTs and primary care physicians who are involved in the healthcare of patients with moderate-to-severe asthma..
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Feel free to pass this invitation on to your physicians, fellows, physician assistants, nurses, pharmacists, healthcare practitioners, and any other colleagues that you believe would be interested in attending this free CME/CNE program.
Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.